ACCU-CHEK AVIVA INSIGHT
Roche Diabetes Care GmbH
Application Filed: 2017-06-30
Trademark Application Details
SECOND EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87512672 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Brent A. Harris |
| Attorney Name | Kenneth J. Waite |
| Law Office Assigned | M70 |
| Employee Name | DELANEY, ZHALEH SYBIL |
Timeline
| 2017-06-30 | Application Filed |
| 2018-08-14 | Published for Opposition |
| 2018-10-09 | Location: INTENT TO USE SECTION |
| 2019-10-03 | Status: Live/Pending |
| 2019-12-05 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Roche Diabetes Care GmbH |
| Address | Sandhofer Strasse 116 68305 Mannheim DE |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Instruments, devices and apparatus for medical and diagnostic purposes, namely, blood glucose meters; lancet and lancet devices, namely, a blood-letting device for obtaining a capillary blood sample; insulin pumps and infusion sets |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-07-04 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-07-10 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-09-27 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2017-09-27 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2017-09-27 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2017-09-27 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-01-25 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-01-25 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-01-25 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2018-01-30 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2018-01-30 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-01-30 | 12 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2018-06-21 | 13 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-07-09 | 14 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-07-10 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-07-10 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-07-10 | 17 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-07-25 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-08-14 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-08-14 | 20 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-10-09 | 21 NOAM E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-01-09 | 22 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-01-09 | 23 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-04-03 | 24 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-04-03 | 25 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-04-03 | 26 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-04-05 | 27 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-02 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-02 | 29 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-10-03 | 30 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-10-03 | 31 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-10-03 | 32 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-05 | 33 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-12-05 | 34 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-12-05 | 35 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2020-04-07 | 36 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-04-07 | 37 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-04-07 | 38 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-09 | 39 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-10-07 | 40 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2020-10-07 | 41 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-10-07 | 42 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-10-09 | 43 EXRA E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-10-09 | 44 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-09 | 45 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-09 | 46 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-10-09 | 47 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-09 | 48 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-10-09 | 49 CHAN I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2021-04-08 | 50 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-04-22 | 51 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2021-04-08 | 52 EXT5 S: |
| EXTENSION 5 GRANTED | 2021-04-22 | 53 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-23 | 54 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2021-11-15 | 55 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-11-15 | 56 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ACCU-CHEK AVIVA INSIGHT 87512672 not registered Live/Pending |
Roche Diabetes Care GmbH 2017-06-30 |
 ACCU-CHEK AVIVA INSIGHT 79088094 3991903 Dead/Cancelled |
Roche Diabetes Care GmbH 2010-09-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 